European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas
G Raverot, P Burman, A McCormack… - European journal of …, 2018 - academic.oup.com
Background Pituitary tumours are common and easily treated by surgery or medical
treatment in most cases. However, a small subset of pituitary tumours does not respond to …
treatment in most cases. However, a small subset of pituitary tumours does not respond to …
How to classify pituitary neuroendocrine tumors (PitNET) s in 2020
J Trouillas, ML Jaffrain-Rea, A Vasiljevic, G Raverot… - Cancers, 2020 - mdpi.com
Adenohypophyseal tumors, which were recently renamed pituitary neuroendocrine tumors
(PitNET), are mostly benign, but may present various behaviors: invasive,“aggressive” and …
(PitNET), are mostly benign, but may present various behaviors: invasive,“aggressive” and …
Aggressive pituitary adenomas—diagnosis and emerging treatments
A Di Ieva, F Rotondo, LV Syro, MD Cusimano… - Nature Reviews …, 2014 - nature.com
The WHO categorizes pituitary tumours as typical adenomas, atypical adenomas and
pituitary carcinomas, with typical adenomas constituting the major class. However, the WHO …
pituitary carcinomas, with typical adenomas constituting the major class. However, the WHO …
Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomas
H Lasolle, C Cortet, F Castinetti, L Cloix… - European Journal of …, 2017 - academic.oup.com
Objectives Only few retrospective studies have reported an efficacy rate of temozolomide
(TMZ) in pituitary tumors (PT), all around 50%. However, the long-term survival of treated …
(TMZ) in pituitary tumors (PT), all around 50%. However, the long-term survival of treated …
Giant prolactinomas: the therapeutic approach
AB Moraes, C Marques dos Santos Silva… - Clinical …, 2013 - Wiley Online Library
Background Giant prolactinomas are an unusual subset of macroprolactinomas and are
more commonly found in men. The goal of this review is to propose a giant prolactinoma …
more commonly found in men. The goal of this review is to propose a giant prolactinoma …
Are aggressive pituitary tumors and carcinomas two sides of the same coin? Pathologists reply to clinician's questions
J Trouillas, ML Jaffrain-Rea, A Vasiljevic… - Reviews in Endocrine …, 2020 - Springer
Pituitary adenohypophyseal tumors are considered as benign and termed “adenomas”.
However, many tumors are invasive and a proportion of these exhibit an “aggressive …
However, many tumors are invasive and a proportion of these exhibit an “aggressive …
Management of endocrine disease: clinicopathological classification and molecular markers of pituitary tumours for personalized therapeutic strategies
G Raverot, E Jouanneau… - European journal of …, 2014 - academic.oup.com
Pituitary tumours, the most frequent intracranial tumour, are historically considered benign.
However, various pieces of clinical evidence and recent advances in pathological and …
However, various pieces of clinical evidence and recent advances in pathological and …
Clinical, pathological, and molecular factors of aggressiveness in lactotroph tumours
J Trouillas, E Delgrange, A Wierinckx, A Vasiljevic… - …, 2019 - karger.com
The behaviour of lactotroph tumours varies between benign tumours, those cured by
treatment, and that of aggressive tumours, and carcinomas with metastasis. Identification of …
treatment, and that of aggressive tumours, and carcinomas with metastasis. Identification of …
Management of aggressive pituitary adenomas and pituitary carcinomas
A Heaney - Journal of Neuro-Oncology, 2014 - Springer
Pituitary tumors are benign but not uncommonly invade locally into adjacent tissues such as
the cavernous sinus and dura. Some of these invasive tumors exhibit varying degrees of …
the cavernous sinus and dura. Some of these invasive tumors exhibit varying degrees of …
Corticotrophic pituitary carcinoma with cervical metastases: case series and literature review
F Yoo, EC Kuan, AP Heaney, M Bergsneider, MB Wang - Pituitary, 2018 - Springer
Purpose Pituitary tumors are the second most common intracranial tumors, however,
pituitary carcinoma is a rare clinical entity which represents only 0.1–0.2% of all pituitary …
pituitary carcinoma is a rare clinical entity which represents only 0.1–0.2% of all pituitary …